30,000,000 people living in the United States today have a rare disease and more than half of these are children.* An annual review of pediatric mortality data shows that 23% of infant deaths are due to genetically determined disorders** and 34% of all pediatric admissions are due to an underlying undiagnosed genetic disease accounting for 50% of hospital charges.***
Integrate the utility of genomic sequencing into your clinical workflow
Why Envision Genomics?
Envision Genomics is a clinical genomics service provider helping clinicians diagnose rare disease through the integration of genomic data into clinical care. Envision is building a network of children’s hospitals and empowering them to practice genomic medicine by providing the end-to-end expertise, infrastructure and resources necessary to implement and deploy clinical genomics.
Be the Genomic Medicine Leader in Your Market, Envision Genomics: Vested in Genomic Medicine, Offering a Comprehensive Genomic Medicine Package, Ending the Diagnostic Odyssey and Reversing Misdiagnosis through Genomic Medicine, The Need is Now, the Solution is Envision Genomics
The Envision board, founders, and leadership team wish to express our profoundest sympathy to the family of Tom Main, our board member and treasured colleague, who died on Sunday, September 16, 2018.
Please see the following article on Tom below: